[HTML][HTML] Molecular diagnostics in the evaluation of thyroid nodules: current use and prospective opportunities
J Patel, J Klopper, EE Cottrill - Frontiers in endocrinology, 2023 - frontiersin.org
Thyroid cancer is the most common endocrine malignancy with an estimated 43,800 new
cases to be diagnosed in 2022 and representing the 7th most common cancer in women …
cases to be diagnosed in 2022 and representing the 7th most common cancer in women …
Molecular diagnostics in the evaluation of thyroid nodules: Current use and prospective opportunities
J Patel, J Klopper, E Cottrill - Frontiers in Endocrinology, 2023 - europepmc.org
Thyroid cancer is the most common endocrine malignancy with an estimated 43,800 new
cases to be diagnosed in 2022 and representing the 7th most common cancer in women …
cases to be diagnosed in 2022 and representing the 7th most common cancer in women …
Molecular Diagnostics in the Evaluation of Thyroid Nodules: Current Use and Prospective Opportunities
J Patel, J Klopper, EE Cottrill - 2023 - jdc.jefferson.edu
Thyroid cancer is the most common endocrine malignancy with an estimated 43,800 new
cases to be diagnosed in 2022 and representing the 7th most common cancer in women …
cases to be diagnosed in 2022 and representing the 7th most common cancer in women …
[引用][C] Molecular diagnostics in the evaluation of thyroid nodules: Current use and prospective opportunities
J Patel, J Klopper, EE Cottrill - Frontiers in Endocrinology (Web), 2023 - jglobal.jst.go.jp
Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. American
Thyroid association management guidelines for adult patients with thyroid nodules and …
Thyroid association management guidelines for adult patients with thyroid nodules and …
Molecular diagnostics in the evaluation of thyroid nodules: Current use and prospective opportunities
J Patel, J Klopper, EE Cottrill - Frontiers in endocrinology, 2023 - pubmed.ncbi.nlm.nih.gov
Thyroid cancer is the most common endocrine malignancy with an estimated 43,800 new
cases to be diagnosed in 2022 and representing the 7th most common cancer in women …
cases to be diagnosed in 2022 and representing the 7th most common cancer in women …
[HTML][HTML] Molecular diagnostics in the evaluation of thyroid nodules: Current use and prospective opportunities
J Patel, J Klopper, EE Cottrill - Frontiers in Endocrinology, 2023 - ncbi.nlm.nih.gov
Thyroid cancer is the most common endocrine malignancy with an estimated 43,800 new
cases to be diagnosed in 2022 and representing the 7th most common cancer in women …
cases to be diagnosed in 2022 and representing the 7th most common cancer in women …
Molecular diagnostics in the evaluation of thyroid nodules: Current use and prospective opportunities.
J Patel, J Klopper, EE Cottrill - Frontiers in Endocrinology, 2023 - europepmc.org
Thyroid cancer is the most common endocrine malignancy with an estimated 43,800 new
cases to be diagnosed in 2022 and representing the 7th most common cancer in women …
cases to be diagnosed in 2022 and representing the 7th most common cancer in women …